1 |
Cholecalciferol
💬
| [1] Cholecalciferol Cholecalciferol | [5] Cholecalciferol Cholecalciferol; COLECALCIFEROL; Multivitamin; Vitamin D; Vitamin D3; | [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [16] 6 6, 13, 19, 20, 34, 46, 49, 51, 53, 60, 65, 96, 97, 228, 298, 299 💬 |
2 |
Budesonide
💬
| [1] Budesonide Budesonide | [4] Budesonide Budesonide; Entocort; Jorveza; Symbicort; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [9] 66 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
3 |
Famotidine
💬
| [1] Famotidine Famotidine | [2] FAMOTIDINA FAMOTIDINA; Famotidine; | [1] HRH2 HRH2 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | [6] 6 6, 46, 61, 86, 98, 107 💬 |
4 |
Lansoprazole
💬
| [1] Lansoprazole Lansoprazole | [1] Lansoprazole Lansoprazole; | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [7] 63 63, 71, 85, 98, 166, 222, 299 💬 |
5 |
Loratadine
💬
| [1] Loratadine Loratadine | [2] Loratadina Loratadina; Loratadine; | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 46, 89, 98 💬 |
6 |
Mesalamine
💬
| [1] Mesalazine Mesalazine | [10] 5-AminoSalicylic Acid 5-AminoSalicylic Acid; 5-ASA; ASACOL; Mesalamine; MESALAZINA; MESALAZINE; Mesalazinum; MEZAVANT; Pentasa; Salofalk; | - | - | [5] 46 46, 96, 97, 98, 164 💬 |
7 |
Sucralfate
💬
| [1] Sucralfate Sucralfate | [1] Sucralfate Sucralfate; | - | - | [1] 98 98 💬 |
8 |
Sevoflurane
💬
| [1] Sevoflurane Sevoflurane | [1] Sevoflurane Sevoflurane; | - | - | [7] 6 6, 21, 22, 34, 98, 225, 296 💬 |
9 |
Propofol
💬
| [1] Propofol Propofol | [2] Propofol Propofol; Propofol Injection; | [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [8] 6 6, 21, 22, 34, 46, 70, 98, 296 💬 |
10 |
Beclomethasone dipropionate
💬
| [1] Beclomethasone dipropionate Beclomethasone dipropionate | [2] BECLOMETASONE DIPROPIONATE BECLOMETASONE DIPROPIONATE; Beclomethasone dipropionate; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 85 85, 97, 98 💬 |
11 |
Mometasone furoate
💬
| [1] Mometasone furoate Mometasone furoate | [3] Mometasone Mometasone; MOMETASONE FUROATE; Nasonex; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 98 98, 162 💬 |
12 |
Sirolimus
💬
| [1] Sirolimus Sirolimus | [3] RAPAMUNE RAPAMUNE; Rapamycin; SIROLIMUS; | [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [40] 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬 |
13 |
Fluticasone propionate
💬
| [1] Fluticasone propionate Fluticasone propionate | [3] Flovent Flovent; Fluticasone; FLUTICASONE PROPIONATE; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 98 98, 228 💬 |
14 |
Infliximab
💬
| [1] Infliximab Infliximab | [6] Flixabi Flixabi; INFLECTRA; Infliximab; REMICADE; Remsima; Zessly; | [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 💬 |
15 |
Arginine
💬
| [2] Arginine Arginine, L-arginine | [6] Arginina Arginina; Arginine; L-Arg; L-Arginin; L-arginine; R-Gene; | - | - | [12] 46 46, 58, 65, 67, 78, 96, 97, 98, 113, 210, 251, 299 💬 |
16 |
Mepolizumab
💬
| [1] Mepolizumab Mepolizumab | [2] MEPOLIZUMAB MEPOLIZUMAB; NUCALA; | [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [4] 44 44, 45, 98, 162 💬 |
17 |
Omalizumab
💬
| [1] Omalizumab Omalizumab | [2] Omalizumab Omalizumab; XOLAIR; | [1] FCER1A FCER1A 💬 | [4] Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [7] 46 46, 53, 65, 98, 162, 226, 299 💬 |
18 |
Citalopram
💬
| [1] Citalopram Citalopram | [1] Citalopram Citalopram; | [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 💬 |
19 |
Cromoglicic acid
💬
| [1] Cromoglicic acid Cromoglicic acid | [4] Cromoglicate Cromoglicate; Cromoglycate; Cromolyn; Cromolyn Sodium; | - | - | [3] 2 2, 85, 98 💬 |
20 |
Esomeprazole
💬
| [1] Esomeprazole Esomeprazole | [3] Esomeprazole Esomeprazole; Nexium; Omeprazole; | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [8] 13 13, 46, 86, 98, 107, 113, 298, 299 💬 |
21 |
Fluticasone
💬
| [1] Fluticasone Fluticasone | [1] Fluticasone Fluticasone; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 98 98, 228, 299 💬 |
22 |
Losartan
💬
| [1] Losartan Losartan | [3] Cozaar Cozaar; Losartan; LOSARTAN POTASSIUM; | [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [17] 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
23 |
Mometasone
💬
| [1] Mometasone Mometasone | [1] Mometasone Mometasone; | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 98 98, 162 💬 |
24 |
Montelukast
💬
| [1] Montelukast Montelukast | [3] MONTELUKAST MONTELUKAST; MONTELUKAST SODIUM; Singulair; | [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [8] 6 6, 13, 46, 61, 63, 85, 98, 228 💬 |
25 |
Potassium
💬
| [1] Potassium Potassium | [1] Potassium Potassium; | - | - | [13] 36 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 💬 |
26 |
Dexlansoprazole
💬
| [1] Dexlansoprazole Dexlansoprazole | [1] Dexlansoprazole Dexlansoprazole; | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 98 98 💬 |
27 |
Reslizumab
💬
| [1] Reslizumab Reslizumab | [1] Reslizumab Reslizumab; | [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 98 💬 |
28 |
Benralizumab
💬
| [1] Benralizumab Benralizumab | [2] Benralizumab Benralizumab; Fasenra; | [1] IL5RA IL5RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [5] 44 44, 45, 98, 162, 299 💬 |
29 |
Dupilumab
💬
| [1] Dupilumab Dupilumab | [2] DUPILUMAB DUPILUMAB; Dupixent; | [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 51 51, 97, 98, 160, 162 💬 |
30 |
Etrasimod
💬
| [1] Etrasimod Etrasimod | [1] Etrasimod Etrasimod; | [5] S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 96 96, 97, 98 💬 |
31 |
Tezepelumab
💬
| [1] Tezepelumab Tezepelumab | [3] AMG 157 AMG 157; MEDI9929; Tezepelumab; | [1] TSLP TSLP 💬 | [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 98 98 💬 |
32 |
Vonoprazan
💬
| [1] Vonoprazan Vonoprazan | [1] Vonoprazan Vonoprazan; | [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2] 63 63, 98 💬 |
33 |
Lirentelimab
💬
| [1] Lirentelimab Lirentelimab | [1] Lirentelimab Lirentelimab; | [1] SIGLEC8 SIGLEC8 💬 | [1] 💬 | [1] 98 98 💬 |